SHA:603168 Revenue

Zhejiang Shapuaisi Pharmaceutical had revenue of 101.73M CNY in the quarter ending March 31, 2025, a decrease of -26.19%. This brings the company's revenue in the last twelve months to 447.86M, down -27.84% year-over-year. In the year 2024, Zhejiang Shapuaisi Pharmaceutical had annual revenue of 483.96M, down -24.96%.

Revenue (ttm)

447.86M

Revenue Growth

-27.84%

P/S Ratio

6.12

Revenue / Employee

337.24K

Employees

1,385

Market Cap

2.74B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	483.96M	-161.01M	-24.96%
Dec 31, 2023	644.97M	95.43M	17.37%
Dec 31, 2022	549.54M	-80.23M	-12.74%
Dec 31, 2021	629.76M	282.96M	81.59%
Dec 31, 2020	346.81M	-169.15M	-32.78%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Jiangsu Hengrui Medicine	29.19B
Shenzhen Mindray Bio-Medical Electronics	35.59B
WuXi AppTec	39.59B
Zhangzhou Pientzehuang Pharmaceutical.,	10.76B
Aier Eye Hospital Group	21.81B
Shanghai United Imaging Healthcare	10.43B
Sichuan Biokin Pharmaceutical	5.82B
Yunnan Baiyao Group Co.,Ltd	40.10B

Revenue Rankings